1st Quarter - Report — ENDO INTERNATIONAL for ENDO INTERNATIONAL (2012)

Firm

ENDO INTERNATIONAL

Client

ENDO INTERNATIONAL

Income

—

Expenses

$700,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Life Sciences Jobs and Investment Act (H.R. 2632, S. 1410).

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Drug Enforcement Administration (DEA)

Bills named: H.R. 2632 (112th), S. 1410 (112th)

Copyright/Patent/Trademark CPT

Patent reform issues (H.R. 1249, S. 23); Pattent settlements (S. 27).

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS	—

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 27 (112th), S. 23 (112th), H.R. 1249 (112th)

Health Issues HCR

Drug reimportation issues (S. 319); Reauthorization of Prescription Drug User Fee Act; Life sciences research tax credit legislation (Life Sciences Jobs and Investment Act--H.R.2632, S. 1410); Healthcare reform bill repeal (H.R. 2); Preserving Access to Orphan Drus Act of 2011 (H.R. 2672, S. 1423); Medicare rebates and reimbursement rates; 340B drug discount program (340B Program Improvement Act--H.R. 2674); Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3998).

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Drug Enforcement Administration (DEA)

Bills named: S. 1410 (112th), S. 319 (112th), H.R. 2672 (112th), H.R. 3998 (112th), H.R. 2 (112th), H.R. 2674 (112th), H.R. 2632 (112th), S. 1423 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.